New York City, NY -- (SBWIRE) -- 01/06/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Chelsea Therapeutics International Ltd. (NASDAQ:CHTP), Inovio Pharmaceuticals Inc (NYSEMKT:INO), Golden Minerals Co (NYSEMKT:AUMN), Gyrodyne Company of America, Inc. (NASDAQ:GYRO)
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) declined -14.63%, trading on 7.23 million shares, to end the trade at $3.50. The stock changed hands in a range of $3.36 to $4.09, bringing its market capitalization to about $274.52 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.76 and was moved to the maximum level of $4.53. Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), associated with primary autonomic failure and falls related to NOH in Parkinson’s Disease (PD), as well as other norepinephrine-related conditions and diseases.
Why Should Investors Buy CHTP After the Recent Fall? Just Go Here and Find Out
Inovio Pharmaceuticals Inc (NYSEMKT:INO) declined -12.89%, to complete the trading session at $2.50, with a total volume of 15.46 million shares. The stock, on average, trades on a volume of 5.09 million shares. It floated in a range of $2.43 to $2.86 during the last trading session, with a beta value of 3.26. Its market capitalization now moved to about $520.94 million. In the past 52 weeks, the share price has not declined below $0.49 and above $3.03. Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens, such as influenza and human immunodeficiency virus (HIV).
Will INO Get Buyers Even After The Recent Rally? Find Out Here
Golden Minerals Co (NYSEMKT:AUMN) recorded a fall of -9.86% and was in a range of $0.55-$0.69 before closing at $0.569. The stock completed the day with a total volume of 1.19 million shares, versus an average volume of 317,478 shares. The share price hit its 52-week low of $0.42 and $4.87 was the best price. Golden Minerals Company (Golden Minerals) is a mining company. The Company owns and operates the Velardena and Chicago precious metals mining operations (the Velardena Operations) in the State of Durango, Mexico, the El Quevar advanced exploration property in the province of Salta.
Will AUMN Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Gyrodyne Company of America, Inc. (NASDAQ:GYRO) declined -9.25%, bringing its market capitalization around $16.00 million. The share price, after opening at $11.50, made a high of $11.50 and hovered above $10.70 to end the day at $10.79. The total number of shares that changed hands during the session was 1.05 million shares, as compared to average trading volume of 280,566 million shares. Gyrodyne Company of America, Inc. (Gyrodyne) is a self-managed and self-administered real estate investment trust (REIT). The Company’s primary business is the investment in and the acquisition, ownership and management of a geographically diverse portfolio of medical office and industrial properties and development of industrial and residential properties.
Is it the Right to Grab GYRO after the Recent Slump? Get Free Trend Analysis Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)